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A B S T R A C T   
Active military personnel are often subject to extreme stressors, whether psychological or physical. Such stressors 
often result in soldiers having severe gastrointestinal diseases and cognitive perturbations such as Post Traumatic 
Stress Disorder (PTSD). Whilst pharmaceutical treatments are available, they are not always the most viable 
option, either because of poor efficacy, side effects, availability or economic detriment. By exploring the po-
tential of beneficial nutritional interventions, it may be possible to establish whether the increased intake of 
certain nutraceuticals (such as polyphenols and prebiotics) could improve psychological and gut health in 
combat soldiers, and reduce the effects that PTSD and related gastrointestinal issues have on health and well-
being. This report investigates the link between prebiotics, polyphenols and cognitive and gastrointestinal health.   
1. Introduction 
The human intestinal commensal microbiota and its metabolic 
products are regarded as important contributors to host health (Cani, 
2018). This mixed community of microorganisms, and its resulting 
functionality, contributes to complex biological processes within the 
mammalian system, and is instrumental in metabolic crosstalk which 
occurs between the host and microbiome (Burcelin, 2016; Qin & Wade, 
2017). 
There is a need to discover the cause of gut disorders and develop 
effective new therapies. This has resulted in a drive to expand research 
into treatment to proactively address issues and control symptoms. 
Although there is a stark lack of mechanistic evidence and only a small 
amount of clinical data, there is accumulating evidence that gut dys-
biosis may be involved in the pathogenesis of many digestive disorders 
(Wang et al., 2017). 
Although it is recognised that diet is one of the most modifiable in-
dicators of human health (Leeming et al., 2019), the human gut 
microbiome is still fairly under-explored as an ecosystem (Arumugam 
et al., 2011; Kho & Lal, 2018; Vrancken et al., 2019). This is despite it 
providing an extraordinary opportunity to reduce the impact of common 
gastrointestinal diseases such as Irritable Bowel Syndrome (IBS) and 
gastroenteritis (El-Salhy et al., 2019), via dietary intervention to modify 
bacterial communities (Staudacher et al., 2017). 
Recent research shows that there is potential for the use of gut 
mediated therapies to treat or at least control symptoms of psychological 
disorders, such as PTSD (Bersani et al., 2020; Leclercq et al., 2016). The 
ability of the gut microbiota to influence the biological state of an in-
dividual has led to an acknowledgement that research into the micro-
biome is an essential part of current and future healthcare strategies 
(Hadrich, 2018). 
Not only is diet one of the most important modifying factors of the 
gut microbiota, but it is also instrumental in regulating stress related 
responses (Shively et al., 2020). This is because diet has an impact on the 
microbiota-gut-brain axis, especially in situations perpetuated by ho-
meostatic challenge (Foster et al., 2017). 
Routes of communication between the microbiota and brain are of 
growing interest and, whilst more information is needed, key compo-
nents have now been identified: the vagus nerve; gut hormone signaling; 
the immune system; tryptophan metabolism; and microbial metabolites 
such as short chain fatty acids (SCFA) (Carabotti et al., 2015). Although 
it may initially seem incongruous that the gut can influence the brain, 
common phrases in most languages such as gut wrenching, gut feeling – 
even butterflies in the stomach - suggest an intuitive understanding of 
such a link between these organs. 
Grasping the importance of the gut microbiome in both neurological 
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and gastrointestinal pathologies and developing treatments is a major 
challenge for 21st century medicine. Nowhere is that need greater than 
in the military. Gastrointestinal illness is an extremely common reason 
for sick visits within military personnel (Riddle et al., 2015) and PTSD is 
present in (71%) of veterans (Armenta et al., 2018). These issues not 
only affect active duty performance but cause detriment to the economy 
of the military, and clearly damage the general well-being of soldiers. 
By studying nutritional interventions such as pro- and prebiotics it 
could be possible, through exploitation of gut microbial communities, to 
develop safe and effective interventions. If this positively influences 
both gut health and the mental state of individual war fighters, it could 
mitigate many military-specific issues that are currently compounded by 
military-relevant physical, physiological and psychological stressors. 
Although a lot of research has been carried out on non-war fighter gut 
and brain health and their interactions, the role of the gut microbiota 
(and how it is affected by stress) is under explored. 
This paper will focus on polyphenols and prebiotics; outlining their 
mechanisms of effect, identifying any crosstalk between different com-
binations and applying this to warfighter-specific problems. It will 
examine the potential for novel nutritional mixes (of prebiotics and 
polyphenols) to directly affect specific bacteria in order to attenuate or 
prevent gut dysbiosis and associated cognitive perturbations during 
stress exposure. By looking at interactive mechanisms, it may also be 
possible to discover whether or not current military MREs (meals ready 
to eat) could have effects on the potential benefits of prebiotics and 
polyphenols added to the military diet. By expanding knowledge on this 
subject and improving understanding of combinatorial nutritional sup-
plementation, it may be possible to establish whether or not it is 
appropriate to treat certain warfighter associated physical and cognitive 
conditions through gut microbiota targeted dietary interventions. By 
examining both gastroenteritis and the neurobiology of cognition, the 
findings of this paper will be relevant to not only warfighter specific 
cases but also general health and wellbeing. 
2. Military specific stressors 
One primary reason to focus on war fighters is because they are in 
highly stressful situations. This paper will attempt to evaluate the po-
tential for polyphenols and prebiotics to mediate stress response, 
whether cognitive or physical. It is important to note that, as there is a 
lack of warfighter specific research, civilian and (where available) 
athlete research will be used. Athletes may be a good representatives for 
war fighters as stressors commonly occurring in those groups are similar, 
i.e. strenuous exercise leading to injuries. 
For the purpose of this study, stress is defined as ‘a disruption in 
homeostasis due to environmental, physical, or psychological stimuli (i. 
e., stressors) that elicits adaptive physiological and behavioural re-
sponses to restore homeostasis (i.e., the stress response)’ (Glaser & 
Kiecolt-Glaser, 2005). Although, as mentioned, this paper will catego-
rise research on non-military personnel, it is still possible to examine 
stressors unique to the military situation. As such, stressors can be 
separated into physical (strenuous exercise, undernutrition, etc.), psy-
chological (anxiety and consequent cognitive demands, etc.) and envi-
ronmental (pathogens, high altitude, etc.) (Weeks et al., 2010). 
Research has correlated these stressors with detriments to health 
such as nutrient insufficiencies, hormone disruption, injury or impair-
ments (musculoskeletal and cognitive), inflammation and immune 
suppression, as well as general illness and infection (Karl et al., 2018). 
Despite the belief that people can build tolerance, or resilience to 
stress (Dienstbier, 1989), it has been established that highly stressful 
situations can affect performance, cognitive abilities, illness and re-
covery time (Wu et al., 2013). It is, therefore, both interesting and 
reassuring that growing evidence has linked many stress related health 
conditions to dysbiosis of the gut, as it might prove to be the case that, by 
manipulating the gut microbiota through nutrition, we may mediate 
such responses in military personnel. 
3. Gut-brain axis 
Though a link between the gut microbiota and the brain has long 
been suspected, it is only in recent years that we have seen evidence of 
causal links between changes in the gut microbiota and brain function 
and behaviour. In vitro research has also revealed the potential molec-
ular mechanisms involved in communication between the gut and the 
brain – the gut-brain axis, as illustrated in Fig. 1. 
Interactions between peripheral intestinal function and cognitive 
and emotional centres of the brain appear to be bidirectional (Sun et al., 
2020), and much research shows that communication is highly associ-
ated with signaling from the gut microbiota (Carabotti et al., 2015). 
Communication within both the central and enteric nervous systems 
(signaling from the gut microbiota to the brain and from the brain to the 
gut microbiota) involves endocrine, immune and neural mechanisms 
(Carabotti et al., 2015; Ma et al., 2019). Though much recent research 
has been in animal models (Park et al., 2013), links between the 
microbiota and the gut-brain axis have been demonstrated by correla-
tions between gastrointestinal disorders such as IBS (Mayer, 2011), and 
cognitive disorders like anxiety or depression (Zheng et al., 2016). 
Research has shown that the brain can affect the structure and 
function of the gut microbiota through modulation of gut motility and 
gut permeability. It has also been shown that through this bidirectional 
mechanism, direct secretion of hormones may directly affect microbial 
gene expression (Martin, Osadchiy, Kalani, & Mayer, 2018). These in-
teractions are thought to be a circular communications loop and any 
disturbance within the loop can result in dysregulation. One example of 
this is where secretion of hormones such as 5-HT from enterochromaffin 
cells is seen to travel towards the gut lumen, potentially resulting In 
microbial alterations (Lund et al., 2018). This is likely a bidirectional 
relationship, where secondary bile acids and short chain fatty acids 
derived from the gut bacteria are responsible for the regulation of 
enterochromaffin cell derived 5-HT synthesis (Mandić et al., 2019). 
Hormones can affect microbial gene expression in other ways, such 
as in the case of the increased virulence of pseudomonas aeruginosa, by 
norepinephrine (Hegde et al., 2009). Though the mechanisms of this are 
not fully understood, it is thought that the direct affectation of norepi-
nephrine on the virulence of bacteria is through enhancement of bac-
terial attachment to host tissue (Freestone, 2013). 
Not only is IBS associated with general detriment to cognitive 
function, but research has directly linked the hyper-arousal and hyper- 
vigilant state of PTSD to IBS as a result of the bidirectional signalling 
of the GBA (gut-brain axis) (Ng et al., 2019). Traditional diagnoses of 
PTSD rely on examination of behavioural symptoms (Spoont et al., 
2010) but more recent evidence (as mentioned) has shown PTSD to be 
linked with immune system and inflammatory changes. IBS has been 
independently associated with PTSD (Iorio et al., 2014). A study showed 
that 36% of patients with IBS met behavioural and psychological criteria 
for diagnosis of PTSD (Irwin et al., 1996). It has also been reported that, 
specifically in female veterans, there was an increase of IBS in those 
diagnosed with PTSD (Savas et al., 2009). 
Psychiatric illness is highly debilitating to some and often one of the 
most dangerous aspects is the risk of relapse. By taking a more holistic 
approach to the treatment of cognitive perturbations, such as exploring 
the potential for modulation of the gut microbiota to treat or lessen 
these, recovery may be improved. 
Associations have also been made between microbiota and stress- 
related changes in behaviour and brain function. For example, one 
study explored whether postnatal microbial colonisation affected neu-
roplasticity and biological systems response. By using germ-free, specific 
pathogen-free and gnotobiotic mice, this study explored the hypothal-
amic–pituitary–adrenal (HPA) reaction to stress. It found that germ free 
mice had a substantially higher hypothalamic-pituitary axis response to 
stress, and that this exaggerated response could be reversed through 
colonisation by a probiotic Bifidobacterium infantis (Sudo et al., 2004). 
This suggests that commensal microbiota can strongly affect the 
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development of the stress response, that changes are not permanent and 
that the introduction of specific bacteria can alter the stress response. 
Though the idea of psychobiotics has been around since 2013 (Dinan 
et al., 2013), the use of bacterial and nutritional interventions has not 
been greatly explored in human studies. When it has been tested on 
humans it has often been on healthy human volunteers rather than 
exploring psychobiotics as a treatment for those in a disease state. 
By looking at inflammatory biomarkers and hormonal levels asso-
ciated with disease states, researchers have been able to associate dys-
regulation of immune function and the HPA axis with an individual 
response to stress and therefore, likelihood to develop PTSD (Neigh & 
Ali, 2016). 
PTSD is often characterised by high pro-inflammatory cytokines and 
low cortisol responses (Gill et al., 2008; Kim, Yoon, et al., 2020; Kim, 
Lee, et al., 2020; Speer et al., 2018, 2019). Analyses have primarily 
shown increases in levels of pro-inflammatory cytokine interleukin (IL)- 
1β, IL-6, tumour necrosis factor (TNF)-α, and interferon (IFN)-γ (Kim, 
Yoon, et al., 2020; Kim, Lee, et al., 2020). Research has shown that 
dysbiosis of the gut may increase susceptibility to PTSD after traumatic 
or high stress events (Leclercq et al., 2016). Furthermore, when stress 
alters the microbiota early in life, it can shape immune homeostasis and 
nervous system for the host (Borre et al., 2014), and increase the risk of 
developing PTSD later in life (Leclercq et al., 2016). It may therefore be 
possible, by targeting this dysbiosis, to manipulate the gut-brain axis 
with nutritional intervention or supplementation in order to reduce the 
likelihood of the occurrence of PTSD. 
Research in mouse models, using intruder stressors, has shown that 
Firmicutes and Bacteroidetes are vulnerable to stress that can cause 
PTSD, and the ratio between these increases with increasing stress 
(Gautam et al., 2018). 
By studying such links and how alterations affect different parts of 
this system, it may be possible to identify novel therapeutic targets to 
address cognitive disorders that have so far been poorly understood. 
Case study research has suggested that treatment of PTSD symptoms 
may alleviate symptoms of gastrointestinal illnesses, like IBS (Weaver 
et al., 1998). 
There is a link between dysbiosis of the gut and cognition, as illus-
trated in a study that involved antibiotic disruption of colonic bacteria in 
adult mice (Fröhlich et al., 2016). The study found that, by treating these 
mice with antibiotics, significant changes occurred in metabolite levels, 
changing expression of certain molecules and hindering specific brain 
functions such as memory. It is posited that cognitive impairment 
correlating with dysbiosis, is related to HPA axis activity and changes in 
the expression of certain tight junction proteins (Fröhlich et al., 2016). 
This direct correlation of dysbiosis to cognitive impairments and 
biochemical alterations is relevant to PTSD. 
Fig. 1. Illustration of the gut-brain axis in the human superorganism. The putative effects of dietary polyphenols and the bidirectional communication of the 
microbiota-gut-brain axis are indicated. GABA: gamma-Aminobutyric acid; SCFA: Short Chain Fatty Acid; 5-HT, 5-hydroxytryptamine. 
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Cirrhosis in veterans can be directly linked to PTSD with changes in 
the gut-liver-brain axis being observed. Studies have shown a lower 
microbial diversity in PTSD, with higher levels of pathogenic bacteria. 
Studies have correlated the increase of some pathobionts such as 
Enterococcus spp. with general poor cognition and have specifically 
linked Shigella spp. with PTSD patients (Bajaj et al., 2019). Interestingly, 
when combat-exposed veterans with PTSD were directly compared to 
combat-exposed patients with no PTSD, functionality was seen to differ 
in the gut-brain axis between the groups, demonstrating that PTSD was 
directly linked to differences in microbial diversity (Bajaj et al., 2019). 
Of further relevance to military personnel is their diet, as an inade-
quate diet has been shown to have a deleterious impact on cognitive 
performance (Gómez-Pinilla, 2008; Lu et al., 2016). In a study during 
which young people were put into a military training environment with 
multiple stressors, increased intestinal permeability was exhibited as a 
response to the stress, and concentrations of microbial metabolites 
in faecal samples were also altered (such as p-cresol which increased, 
and benzoate metabolites which decreased), with decreases in Bacter-
oidetes and increases in Firmicutes also being observed (Karl et al., 
2017). 
4. The gut microbiota 
The human gut microbiome, comprised of various organisms such as 
bacteria, viruses, parasites and other microbes, has an enormous effect 
on health and disease outcomes (Clemente et al., 2012). This can be as a 
result of contributions to metabolic function which enhance resistance 
to disease by both improving immunity and protecting against patho-
gens. Through this metabolic action, the gut microbiome affects many 
human physiological functions. The majority of gut microbes are 
beneficial (or harmless) but dysbiosis is associated with diseases such as 
Inflammatory Bowel Disease (IBD) Irritable Bowel Syndrome (IBS), 
psychological/neurological disorders, certain cancers and obesity 
(Zhang et al., 2015). Dysbiosis can be defined as any change to the 
composition of resident commensal communities relative to the com-
munity found in healthy individuals (Petersen & Round, 2014). This 
discovery has improved understanding of how the microbiota may be 
modulated as a response to human health and has shown that the gut 
microbial community should be considered as a whole, rather than 
focussing on individual bacteria (Thursby & Juge, 2017). 
Because gut microbiome profiles vary from individual to individual, 
specific characteristics of a healthy gut microbiome cannot be narrowly 
defined (Bäckhed et al., 2012; Conlon & Bird, 2014; Human Microbiome 
Project, 2012). Over 1000 phylotypes exist in the human gut but most of 
these belong to a few phyla: Bacteroidetes and Firmicutes are predom-
inant, with other more minor constituents also commonly present 
(Rinninella et al., 2019). Examples of healthy adult microbiota have 
some gut bacterial species in common and, through culture-based 
studies, this has come to be considered as a ‘core microbiota’ (Gui-
nane & Cotter, 2013; Ursell et al., 2012). However sequencing research 
has demonstrated that microbiota are highly temporally and spatially 
variable in the colon, which calls into question the validity of the idea of 
a ‘core’ microbiota (Parfrey & Knight, 2012; Ursell et al., 2012). 
Although the idea of this ‘core’ microbiota may no longer be universally 
accepted, a review paper has suggested that, alternatively, a core 
microbiome is shared by healthy gastrointestinal tracts (Lozupone et al., 
2012). Though the terms are often used interchangeably, usually, 
microbiota refers to the actual bacteria, whereas the term microbiome 
often is used in a more functional capacity, describing the bacteria and 
their genes. The gut microbiome may be functionally highly similar, 
whilst hosting many different microbiota species due to varying envi-
ronmental influences. 
It is important that we understand effects that such environmental 
variations have on human health, as this may account for individuals’ 
differing responses to drugs or dietary components. Host-specific re-
sponses to certain foods may involve pathways outside common 
functional metabolism (i.e. differential microbial metabolism). This is 
illustrated by a study which focused on the potential health benefits of 
consuming soy products. Many health benefits associated with soy 
consumption have been shown to be associated with the bacterial 
metabolism of soy isoflavone daidzein to S-(-) equol (Mayo et al., 2019). 
However, production of this beneficial compound seems to be reliant on 
habitual consumption of soy as shown by Rowland et al. (2000). This 
was further demonstrated by a comparison of studies on equol produc-
tion in western countries versus those in Japan, Korea or China where 
soy was consumed as part of a habitual diet. It was shown that, while a 
non-western diet had a 50–60% occurrence of S-(-)equol upon dietary 
soy intake, the adult population of western countries produced only 
around 25–30% (Miura et al., 2016). This is interesting, not only 
because it demonstrates ways in which habitual diet can affect the 
processing of food components, but also because it has potential rami-
fications in medicine as key microbiota differences may affect drug 
metabolism in different populations. 
Having established that habitual diet affects how dietary compo-
nents are metabolised, it is also important to understand and explore 
resilience of the gut microbiota – in short – how much can the response 
to certain functional foods be changed by diet, for how long and how 
quickly? This is important when considering therapeutic diets such as 
introducing prebiotics, probiotics or polyphenol compounds. Human 
studies have usually demonstrated statistically significant changes to the 
microbiome when diet is changed over a period of time, for example, 
differences have been seen after 10 days of a high fibre diet (Wu et al., 
2011). However, it is important to note that some changes in micro-
biome composition in one study were actually detectable within 24 h of 
controlling the diet (Wu et al., 2011). This was further confirmed in 
studies on gnotobiotic mice which demonstrated that switching from a 
low fat, plant polysaccharide rich diet to a high fat, high sugar western 
diet caused structural changes in the microbiota within a day. Not only 
was structure altered, but also gene expression and metabolic pathways 
in the microbiome (Turnbaugh et al., 2009). It is important however to 
note that, although these changes are observed and may have effects on 
potential health benefits conferred by eating certain foods (as in the case 
of soy), differences are still minimal compared to simple interpersonal 
variation. 
The gut microbiota affects digestion and host nutrition by breaking 
down non-digestible substrates. This symbiotic relationship provides 
strong evidence of the importance of the gut microbiota for host health 
(Makki et al., 2018). One way that digestion of substrates contributes to 
host health is by releasing short chain fatty acids (SCFA) from indi-
gestible fibres. SCFA may help modulate both the immune response and 
tumorigenesis in the gut (Bishehsari et al., 2018; Chambers et al., 2018). 
The abundance of many bacteria may be inversely correlated to 
several disease states (Arboleya et al., 2016; Heiman and Greenway, 
2016). It may therefore be possible to utilise dietary components to 
selectively enhance the growth of beneficial bacteria that improve host 
health (Zhang et al., 2015). While there is considerable research on the 
use of probiotics to improve gut microbiome health, prebiotics can also 
be used to maintain and improve health through nutritional in-
terventions that increase the activity of bacterial groups such as Bifido-
bacterium and Lactobacillus spp. (Singh et al., 2017). 
5. Pro, Pre, synbiotics and polyphenols – A brief introduction 
The inclusion of probiotics, prebiotics or synbiotics into the human 
diet can favourably alter the intestinal microbiota. According to the 
latest definition by the International Scientific Association for Probiotics 
and Prebiotics, (ISAPP) probiotics are ‘live microorganisms that, when 
administered in adequate amounts, confer a health benefit on the host 
(Hill et al., 2014). Probiotics have been shown in clinical studies to have 
a positive effect on gastrointestinal diseases (Allen et al., 2004; Dale 
et al., 2019; McFarland, 2006) as well as disorders such as diabetes (Tao 
et al., 2020). Research has also shown that probiotics can aid the body’s 
B. Sayers et al.                                                                                                                                                                                                                                  
Journal of Functional Foods 87 (2021) 104753
5
immunity (Vanderpool et al., 2008) and be used prophylactically to 
attempt to prevent certain cancers (Kim & Jin, 2001; Lidbeck et al., 
1991). 
A prebiotic is defined by ISAPP as “a substrate that is selectively 
utilized by host microorganisms conferring a health benefit” (Gibson 
et al., 2017). Prebiotics stimulate the growth of different gut bacteria 
and can have a large effect on the modulation of the gut microbiota 
(Chung et al., 2016). Health benefits conferred from the intake of pre-
biotics can vary, but research has shown that prebiotics can aid in 
metabolic health (Kellow et al., 2014), allergic health (Brosseau et al., 
2019), and gastrointestinal health (Lindsay et al., 2006; Welters et al., 
2002). Prebiotics are found in fruit, vegetables, fermented foods, and 
can also be ingested through supplementation, as can probiotics (Mar-
kowiak & Śliżewska, 2017). 
The term synbiotic was first introduced by Gibson and Roberfroid 
(Gibson & Roberfroid, 1995), and was described as a combination of 
synergistic probiotics and prebiotics, but in 2019 the definition was 
updated to “ a mixture comprising live microorganisms and substrate(s) 
selectively utilized by host microorganisms that confers a health benefit 
on the host” (Swanson et al., 2020). Synbiotics aim to aid the survival of 
probiotics in the gastrointestinal tract thereby, theoretically, improving 
their efficacy (Peña, 2007). 
Plant polyphenols are compounds that may also meet the criteria of 
prebiotics (Gibson et al., 2017) and, whilst more evidence is needed, the 
health benefits linked to polyphenol consumption are associated with 
metabolites produced after microbial metabolism (Dueñas et al., 2015). 
Polyphenols are a large group of phytochemicals, with enormous vari-
ation in both structure, function and metabolite production (Tsao, 
2010). 
6. Prebiotics 
The primary bacteria ‘targeted’ by prebiotics are Bifidobacterium and 
Lactobacillus, as these have evidence of health promoting effects 
(Manning & Gibson, 2004). Established prebiotics (through in vivo 
studies) include inulin, fructo-oligosaccharides (FOS) and galacto- 
oligosaccharides (GOS), although there are other compounds that also 
meet the criteria of this definition (Davani-Davari et al., 2019). These 
are other oligosaccharides, algae, resistant starches, and polyphenols, 
which may positively affect bacteria within the gastrointestinal envi-
ronment although there is less in vivo evidence than for fructans or 
galactans (Gibson et al., 2017) 
By selectively modifying the gut microbiota through prebiotics, we 
may not only induce beneficial effects in the colon and surrounding 
digestive tract, but also potentially benefit other areas of the body. 
Research has shown that the prebiotic effect is associated with im-
provements in the activities of the immune system, and biomarker levels 
such as blood lipids (Markowiak & Śliżewska, 2017). 
7. Mechanism of prebiotic action: 
One of the primary mechanisms by which dietary fibre and other 
prebiotics change the gut microbiota is through fermentation in the 
colon (Slavin, 2013). The majority of bacteria in the human body are in 
the large intestine and this is the most diverse and metabolically pro-
ductive area of the body (Louis et al., 2016). Due to a slow transit time, 
anaerobic conditions, favourable pH and readily available nutrients, 
bacterial growth is extensive therein. Bacteria that are potentially 
beneficial are often those with a solely saccharolytic metabolism, such as 
the lactobacilli and bifidobacteria mentioned previously (Ouwehand 
et al., 2005). The primary fermentation pathway generates pyruvate 
from hexoses in undigested carbohydrates (Oliphant & Allen-Vercoe, 
2019). Then, colonic bacteria hydrolyse many of these to produce 
CO2, SCFA and other compounds, some generating energy from the 
fermentation (Slavin, 2013). SCFAs can be absorbed into the blood-
stream and some, like acetate, are metabolised systematically 
(Hernández, Canfora, Jocken, & Blaak, 2019). The production of SCFAs 
through fermentation in the colon is also thought to repress pathogen 
growth by reducing the intestinal pH (den Besten et al., 2013). One 
positive aspect of the introduction of prebiotics to improve host health is 
that prebiotics occur naturally in many foods, such as garlic, onions, 
soybeans, wheat, banana, asparagus, artichoke and oats (Slavin, 2013). 
Although fibre and thereby, some prebiotics, are recommended in 
nutritional guidance, their intake is small in western diets (Holscher, 
2017). It may be possible however, to confer health benefits to those 
unable to consume the necessary amounts by nutritional interventions 
such as fortification of foods with prebiotics. If we consider polyphenols 
to have a prebiotic effect, highly concentrated derivatives of plants 
containing these, as well as other prebiotic supplements, could be added 
to foodstuffs. 
One often overlooked group of people unlikely to consume enough 
prebiotics (to counteract the harmful effects of physical and mental 
stress) is combat soldiers. Military personnel have to operate under 
conditions that civilians would not usually be subjected to, for example: 
poor sleep; less than ideal nutrition; extreme environments e.g. altitude, 
all of which can lead to elevated stress (Hill et al., 2011; Karl et al., 
2018). Due to the nature of their job, combat soldiers are often required 
to perform their roles despite these suboptimal conditions, which has the 
potential to lead to poor health outcomes including cognition. 39% of 
military personnel report feeling a great deal of stress in their work and 
it is possible that these stressors and associated issues could dictate 
mission success or failure (Bray et al., 2001). It is therefore within the 
best interests of the military to ensure that everything possible is done to 
ensure optimum cognitive and physical performance of military 
personnel. Studies have demonstrated that, although the gut micro-
biome does generally display some stability, it is possible for stressors to 
alter gut microbiome composition (Karl et al., 2018). Gut microbiota 
could, therefore, be manipulated to modulate the human stress response 
to improve host health, and growing evidence does show that a healthy 
gut microbiota has positive effects on military performance (Arcidia-
cono et al., 2018). 
Not only could acute stress hamper performance (Bray et al., 2001) 
but continued and chronic stress and trauma experienced by some 
military personnel may result in cognitive perturbations such as PTSD 
(Iribarren et al., 2005). The prevalence of PTSD in military personnel 
may be twice as high as in civilian populations (Spottswood et al., 2017). 
The gut microbiome is known to have a critical role within the brain- 
gut axis, and in regulation of intestinal permeability, (Carabotti et al., 
2015; Kelly et al., 2015), so nutritional supplementation to improve 
function of the gut microbiome may be fundamental when considering 
the treatment and prevention of PTSD. Because of its association with 
low grade inflammation, PTSD may result in deficits in intestinal 
permeability (Bersani et al., 2020; Kim, Yoon, et al., 2020; Kim, Lee, 
et al., 2020; Leclercq et al., 2016). Therefore, it is feasible that treatment 
(curative and proactive) through manipulation of the gut bacteria by 
nutritional intervention, could benefit military personnel. It is also 
important to note that, while a diet of USA military food rations alters 
faecal microbial composition, it does not directly increase intestinal 
permeability (Karl et al., 2019). 
It has been postulated that prebiotics provide a protective effect on 
cognition through aiding of production of Brain-derived neurotrophic 
factor (BDNF) (Burokas et al., 2017; Franco-Robles & López, 2016). This 
is particularly relevant to those in high stress situations, as BDNF has 
been shown to decrease when acute stress occurs. In brief, supplemen-
tation with prebiotics such as inulin, will possibly modulate the gut- 
brain axis, by increasing BDNF levels and reducing pro inflammatory 
cytokine concentration. One study (Romo-Araiza et al., 2018) using a 
mouse model suggests that the prebiotics increase the effects of bene-
ficial bacteria, or probiotics, thus increasing butyrate production, which 
results in these positive changes. By increasing the intake of prebiotics, 
and therefore promoting an increase in the microbial diversity, cogni-
tion may be protected. A study has further supported the association 
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between prebiotics and BDNF by supplementing rats with a prebiotic, 
showing that the levels of BDNF were elevated in the prebiotic group, 
compared to a control (Williams et al., 2016). 
Although probiotic supplements have been studied in relation to 
improving individual performance (Agans et al., 2020), the use of pre-
biotics is relatively under explored in this population. Research has 
shown that prebiotic supplementation can alter cognitive states in some 
individuals, including increased attention to positive emotional cues and 
improved mood (Schmidt et al., 2015). Other studies have shown that 
consumption of inulin resulted in better accuracy in recognition memory 
tasks, and improved recall performance (Smith et al., 2015). 
8. Polyphenols 
Polyphenols are ubiquitous plant chemicals. They are structurally 
categorised by the presence of large multiples of phenol structural units 
and have, in recent years, become a focus of nutritional research. Due to 
their abundance in plants, they naturally form a part of the human diet 
and evidence suggests that consumption of these molecules is a key 
modulator of human health. Though previously thought to be due to 
direct antioxidant effects, beneficial modulation of both physical and 
cognitive health by polyphenols is now widely accepted to be due to 
interactions with the gut microbiota, with metabolites of these in-
teractions providing beneficial effects throughout the host system 
(Kennedy, 2014). 
There are over 8000 types of polyphenol (currently identified) but 
they are broadly categorised (as a function of the number of phenol rings 
that they contain and on the basis of structural elements that bind these 
rings to one another) into flavonoids (which account for roughly 60% of 
all polyphenols), phenolic acids, stilbenes and lignans (Pandey & Rizvi, 
2009; Tsao, 2010). 
Polyphenols can be generally divided into two main groups – Fla-
vonoids and non-flavonoids. The flavonoids are split into six groups: 
flavonols, flavones, flavanols, flavanones, isoflavones, and anthocyanins 
(Abbas et al., 2017), and non-flavonoids include stilbenes, lignans and 
phenolic acids (Pandey & Rizvi, 2009). 
Polyphenols may initially be absorbed in the small intestine, often, 
though not always, conjugated with sugars or organic acids (although 
this usually only occurs with those structures that are mono or dimeric 
(D’Archivio et al., 2010)). This releases aglycones which enter the in-
testinal cell lining and undergo biotransformation, after which meta-
bolic products are spread round the body or excreted (D’Archivio et al., 
2010). Other, more complex structures will reach the colon intact, and 
can be metabolised therein by the gut microbiota. This transformation is 
mediated by microbial enzymes, and may include demethylation and 
decarboxylation, amongst other processes (Chen et al., 2018). It is 
important that we understand biotransformations mediated by phase I 
and II reactions in polyphenols, as it is these phases of metabolism that 
cause low bioavailability (in contrast with high bioactivity) (Luca et al., 
2020). Poor absorption of dietary polyphenols results in extensive 
metabolism within enterocytes and the liver by phase I and II enzymatic 
reactions, followed by biotransformation by the gut microbiota into 
varying structures that can be circulated in the blood (Luca et al., 2020). 
One study estimated that less than 5% of dietary polyphenol intake is 
absorbed and reaches plasma unchanged (Faria et al., 2014). As 
mentioned above, low bioavailability/high bioactivity paradox means 
that metabolites, whether through enzymatic transformation or micro-
bial degradation, are of great interest to the scientific community as they 
demonstrate significant mechanistic effects (Luca et al., 2020). 
Known to be secondary metabolites in plants, dietary polyphenols 
are primarily involved in defence against oxidative damage (ultraviolet 
radiation) or damage caused by pathogen aggression. In humans, these 
protective effects seem to be transferred, and long-term consumption of 
diets high in plant polyphenols may protect the human superorganism 
against: cancer development and progression (green tea) (Yuan et al., 
2018); cardiovascular disease (Khurana et al., 2013); neurodegenerative 
diseases (Mandel & Youdim, 2004)), and other chronic diseases (Jelena 
et al., 2018; Pandey & Rizvi, 2009). Polyphenol consumption has also 
been associated with modulation of human health through anti- 
inflammatory properties (Zhang & Tsao, 2016). There is much evi-
dence that supports associations between the consumption of poly-
phenols and a reduced risk of chronic disease, and many reviews and 
research have stated that although specific classes of compounds are yet 
to be quantified and explored sufficiently to give specific recommen-
dations, a diet high in polyphenol containing foods should be encour-
aged (Del Bo et al., 2019; Knekt et al., 2002). 
One of the reasons that it is difficult to establish specific recom-
mendations when exploring the protective effects of polyphenols is large 
methodological variation when collecting data (Del Bo et al., 2019). 
Furthermore, many intervention studies see a much higher dose of 
polyphenol content being administered than is realistic for a human to 
consume in a ‘normal’ healthy diet. (Williamson, 2017). There may also 
be different mechanistic actions of polyphenol isolates versus wholefood 
consumption – we see in broccoli, for example, that supplementation 
does not have the same beneficial effects as consumption of the whole 
food (thought to be due to a lack of the enzyme Myrosinase in supple-
ments (Clarke et al., 2011; Gautam et al., 2018), so this should also be 
taken into consideration. Another difficulty when evaluating the effi-
cacy of polyphenols in protecting human health is their myriad struc-
tures, each of which has a different metabolic pathway and 
physiological roles, which means that each individual compound’s 
health effects should be explored – both long and short term (Carbonell- 
Capella et al., 2014). Whilst it is reasonable to recommend polyphenol 
intake, guidelines for supplementation need to be established. 
One benefit of polyphenols is that they are often found in foods 
already associated with a healthy diet. Whole plant foods, such as fruits 
and vegetables, are high in polyphenols and the consumption of these 
foods is known to be safe and beneficial. Some specific foods that are 
high in polyphenols include green tea, cocoa, blueberry and cranberry, 
coffee, cereals, as well as nuts, seeds and vegetables such as artichoke 
(Pérez-Jiménez et al., 2010). We should note that, because deficiencies 
in polyphenol intake do not result in deficiency diseases (except in the 
case of general malnourishment), it is difficult to define appropriate 
reference intake values for such food components (Fraga et al., 2019). 
Though many plant foods contain polyphenols, this paper will pri-
marily focus on those that exist in tea, cocoa and berries (blueberry and 
cranberry). Before ndiscussing these specific foods, however, it is 
important to consider the types of polyphenol structures and differential 
bacterial metabolism. Considering the differing structures is important 
as variations will cause differences in physicochemical factors, such as 
digestibility. In order to assess bioavailability and metabolic influence of 
polyphenolic compounds, one must first, therefore, explore bio- 
accessibitfuedlity. 
9. Bioactivity of dietary polyphenols 
Inter-individual variation of the human gut microbiome means that 
there are many possible metabolic pathways that could be used by 
microbiota to contribute to bioavailability of dietary polyphenols 
(Manach et al., 2004). Due to this differential processing amongst 
humans, it is difficult to characterise specific mechanisms by which 
polyphenols are considered bioactive, and by which specific microbial 
species they are transformed (Cardona et al., 2013). Fig. 3 illustrates 
this. 
As previously mentioned, there is diversity within the structure and 
function of dietary polyphenols. lower molecular weight polyphenols 
are likely to be immediately absorbed into the small intestine, whereas 
more complex polyphenols may reach the colon unchanged. 
These larger weight polyphenols undergo enzymatic (α-rhamnosi-
dase, β-glucosidase, and β-glucuronidase) transformation by the gut 
microbial community, breaking these structures into metabolites that 
can be absorbed, and are likely to be responsible for the health benefits 
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correlated (Fig. 2)with the consumption of polyphenol rich foods (Duda- 
Chodak et al., 2015). 
It is important to note that whilst polyphenols are present in food in 
the free form, they are also found bound to other compounds, like within 
the dietary fibre matrix (Jackson & Jewell, 2017; Pandey & Rizvi, 2009). 
This makes them an interesting focus as a combinatorial product with 
prebiotics, many of which are dietary fibre. The stimulation of the gut 
microbiota by dietary fibre to produce specific microbial metabolites 
makes understanding the interactions between these compounds crucial 
(Kardum & Glibetic, 2018). It is plausible that polyphenols may also 
have a prebiotic effect (Alves-Santos et al., 2020), and that the dietary 
fibres present in the plant compounds might facilitate the transport of 
polyphenols to the colon. 
The use of cereals as a food that contains both polyphenols and di-
etary fibre is a fantastic option, wherein bioavailability is extended and 
thereby the putative health benefits of polyphenol consumption is 
improved. 
However, there is dietary fibre in many other foods, such as berries 
(Dreher, 2018), so this beneficial effect is not likely limited to just 
cereals. 
There is an established, general, pattern of polyphenol metabolism, 
whereby natural polyphenols are transformed via a few general pro-
cesses, such as deglycosylation, dehydroxylation and demethylation. 
Microbially modified phenolic metabolites will either be absorbed into 
the body or excreted in urine and faecal matter. Those that are absorbed 
may undergo Phase II metabolism before being circulated around the 
body (Mosele et al., 2015). 
Research has shown that the main genera involved with phenolic 
degradation are Clostridium and Eubacterium, spp. which differs from the 
primary genera associated with intake of prebiotics (Selma et al., 2009). 
It is also important to consider that the action of polyphenols on 
bacterial cells can differ –mechanisms will change depending on bac-
terial wall composition. The action may inhibit or encourage bacterial 
growth (Puupponen-Pimia et al., 2005). Compounds from green tea 
extracts have been seen to modulate certain bacteria (Jung et al., 2019), 
and blueberry extract has shown to increase bifidobacteria in the gut 
(Vendrame et al., 2011). 
After consumption of flavonoids, sugar moieties may be removed 
and absorbed in the small intestine. Hydrolysis will occur in those fla-
vonoids that are glycosylated, by action of β-glucosidase (amongst 
others), and these aglycones will then passively diffuse into epithelial 
cells (D’Archivio, 2010). It is important to note that, where rhamnose 
moieties exist, these flavonoids can reach the colon and may be 
hydrolysed by Bifidobacterium spp. through α-rhamnosidases (Bang 
et al., 2015). 
Whilst, as mentioned, anthocyanins are one of the flavonoid groups, 
one of the ways they can be metabolised is by the transformation into a 
non-flavonoid, specifically phenolic acids (Keppler & Humpf, 2005). 
There are not many free circulating anthocyanins, and this is largely due 
to the metabolism by the gut microflora into phenolic acids (Han et al., 
2021). 
One of these phenolic acids, protocatechuic acid, is especially potent 
in its beneficial effects towards host heath. Though some research sug-
gests that the primary precursor for the dihydroxybenzoic acids is the 
catechin group, protocatechuic acid has been consistently identified as a 
major metabolite of the anthocyanins (Wang et al., 2010). It has many 
putative health benefits, including tumoricidal properties, such as the 
induction of apoptosis in human leukaemia cells. It has also been shown 
to have significant neuroprotective effects, more specifically, protective 
against oxidative stress, and nitrosative stress (Winter et al., 2017). The 
bioactivity of the anthocyanins is thought to be largely due to these 
circulating microbial metabolites, which also remain longer in relevant 
tissues than the anthocyanins themselves (Tsuda et al., 1999). Proto-
catechuic acid is also more stable against metabolism by microflora than 
anthocyanins. (Fleschhut et al., 2006; Woodward et al., 2011). 
Finally, the interaction between gut microflora and anthocyanin 
consumption is further solidified by in vitro studies suggesting that 
anthocyanins enhance the growth of Bifidobacterium spp. And Lactoba-
cillus-Enterococcus spp (Hidalgo et al., 2012). 
10. Molecular mechanisms related to polyphenol metabolites 
As discussed, while there is variation in both the polyphenol meta-
bolism and inter-individual microbial metabolism, most, if not all, 
polyphenols must reach the colon and undergo microbial or enzymatic 
transformations to ensure bioactivity and produce beneficial effects 
(Marín et al., 2015; Pandey & Rizvi, 2009). 
One study looking at quinine metabolites directly linked the intake of 
polyphenol and metabolites to the stress response and specific gene 
regulation. Research showed that, by activating transcription factor 
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), an adaptive stress 
response could be induced (Lee-Hilz et al., 2006). NRF2 has been highly 
associated with antioxidant effect genes that encode for antioxidant 
proteins and detoxification enzymes (Eggler et al., 2008)). This 
Fig. 2. Potential gut microbial associated effects of common dietary polyphenols on the human superorganism.  
B. Sayers et al.                                                                                                                                                                                                                                  
Journal of Functional Foods 87 (2021) 104753
8
association occurs because Nrf2 is regulated by a cysteine-rich protein, 
and quinones are able to act as acceptors that modify cysteine residues, 
leading to nrf2 activation and antioxidant response gene production 
(Eggler et al., 2009). 
Many other polyphenols have been shown to potentially activate 
Nrf2, providing further evidence of the antioxidant and anti- 
inflammatory properties of polyphenols (Hussain et al., 2016). 
Because there is a two-way relationship between the gut microbiota and 
polyphenols (Ozdal et al., 2016), it is important that the specific 
mechanisms of metabolite action are further explored so that people in a 
disease state can benefit as effectively as possible from the intake of 
polyphenol rich foods. 
Several studies have suggested certain polyphenolic compounds can 
benefit athletic performance (Myburgh, 2014) but literature has not, to 
date, provided a comprehensive review on benefits to military 
personnel. 
Research consistently demonstrates the successful use of bioactive 
plant compounds, such as polyphenols, in reducing oxidative damage by 
reducing inflammation and influencing the immune response (Hussain 
et al., 2016). When experiencing extreme physical conditions such as 
endurance, fatigue or stress, one of the most damaging effects on the 
body and brain is from the increased oxidative damage caused by excess 
release of ROS (He et al., 2016; Hussain et al., 2016) As previously 
mentioned, polyphenols protect plants from oxidative damage and it is 
believed that these phytochemicals will have a similar effect in humans, 
albeit through different mechanisms (Pandey & Rizvi, 2009). Though 
artificial antioxidant supplementation may have some benefits, optimal 
doses of polyphenols have not been identified, making the likely success 
of supplements difficult to assess (Myburgh, 2014). This is because 
mechanisms and bioavailability of all polyphenols have not been accu-
rately or completely described, partly due to variable interaction with 
the gut microbiota. Consequently, supplementation may be slightly less 
desirable (Cory et al., 2018; Myburgh, 2014) than consumption of whole 
plant foods. Furthermore, research also suggests that one of the benefits 
of consuming polyphenols in plant foods derives from their interaction 
with other nutrients; for instance the presence of other foodstuffs lessens 
post-prandial glucose spikes because the polyphenols interfere with 
carbohydrate digestion rates (Williamson, 2013). It would be useful to 
identify the specific bacterial gene expression associated with poly-
phenol intake and metabolism, but there has not been enough research 
in human studies to confirm this. 
In such a substrate rich environment as the gut, it is difficult to 
identify specific bacterial expression because the gut microbiome is such 
a complex ecosystem, and it is known that cross-feeding occurs. It may, 
however, be possible to determine which substrates are metabolised first 
and which would be especially useful in terms of identifying interactions 
between carbohydrates and polyphenols. Pure culture studies have 
shown this in the case of NRF2, as mentioned above. However, this is 
difficult to extrapolate to the gut microbiota as we cannot separate out 
individual compounds and the experiments would also need to be 
repeated in a mixed community of microbes. 
11. Specific foods with high polyphenol concentration 
11.1. Blueberries 
Studies have found that blueberries can reduce oxidative stress in 
athletes, possibly due to their antioxidant effect. Although this partic-
ular study was on athletes under heat stress (hyperthermic environ-
ments), athletes or military personnel under other stressful conditions 
such as high altitude may also benefit from a reduction in oxidative 
stress. This would suggest that blueberry supplements could be a useful 
addition to their diet. (McAnulty et al., 2004) Research has also 
demonstrated the effects of blueberries on metabolic diseases and sug-
gests that the polyphenol content is responsible for the prevention of 
metabolic disease through modulation of the gut microbiota (Curtis 
et al., 2019). 
Not only do blueberries seem to have an effect on the prevention of 
Fig. 3. Schematic illustration of the metabolic fate of dietary polyphenols in the human intestinal system. The routes shown include Phase I and Phase II metabolism, 
direct absorption into the small intestine, microbial metabolism, and entering into systemic circulation or excretion into urine. 
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metabolic disease, they are also associated with improved cognitive 
processing. A study showed that, in cognitively impaired adults, per-
formance was altered after blueberry supplementation, with semantic 
access, memory and processing speed all improving (Krikorian et al., 
2020). It is important to note that it is difficult to assess the absorption of 
blueberry polyphenols in studies such as this because, due to the phase II 
metabolites, there was no difference in urinary excretion of anthocya-
nins (Krikorian et al., 2020). This study also showed that those older 
adults who had ongoing blueberry intake before developing dementia 
maintained better cognition (Krikorian et al., 2020). As dementia is 
considered to be at least in part due to inflammation (Peila & Launer, 
2006), it is likely that blueberries may have a similar impact on other 
inflammatory cognitive disorders, such as PTSD. 
Supplementation of polyphenols in young people has also been 
shown to be beneficial; participants given an extract of grape and 
blueberry in one trial showed an improvement in cognition (Philip et al., 
2019). This provides justification for further research into the use of 
polyphenol rich supplements to improve memory and attention, which 
would be of use to military personnel. 
Not only do blueberries appear to play a role in the amelioration of 
cognitive impairments, but they also seem to improve ‘healthy’ cogni-
tion (Whyte et al., 2020). As it is well known that polyphenols rely 
heavily on the gut microbiota for bioavailability, it is likely that meta-
bolism through the microbiota will be instrumental in this. Blueberry 
extracts have also been demonstrated to increase Bifidobacterium and 
Lactobacillus, shown through fluorescent in situ hybridisation (FISH) 
analysis (Molan et al., 2009). 
11.2. Green tea 
Results from several studies into green tea suggest that it would be an 
advantageous addition to a military diet. For example: green tea extract 
(GTE) may be beneficial for reducing the impact that cumulative fatigue 
has on athletic performance, through lessened muscle damaged and 
lower magnitudes of oxidative stress. Military personnel are often sub-
jected to cumulative fatigue (Machado et al., 2018). This study also 
showed that GTE supplementation confers positive effects on neuro-
muscular function as a response to cumulative fatigue. 
A 2018 study showed that, when green tea polyphenols were intro-
duced into mice with high fat induced obesity, there were significant 
differences in differentially expressed genes (through KEGG pathway 
analysis) in ABS transporters and amino acid biosynthesis (Zhang et al., 
2018). This suggests that intake of green tea polyphenols did have an 
effect on metabolic pathways and consequent gene expression. Though 
this was an artificial/environmentally induced microbial imbalance 
(through the high fat diet imposed on the mice) it provides a good basis 
for further human studies in the exploration of green tea polyphenols 
and metabolic pathways affected, especially when considering that the 
bioactivity of green tea polyphenols is made possible by transformation 
of compounds in the gut. This study was able to demonstrate that dys-
biosis seen in the mouse gut after the high fat diet was mitigated by the 
intake of green tea polyphenols. Firmicutes were found to be less 
abundant and Bacteriodetes more abundant in faecal samples post 
intervention. However, there was much individual variation, probably 
as a result of the gut microbial variability between individuals. This 
symbiotic relationship between the gut microbiome and polyphenols 
needs clarification and further study (Zhang et al., 2018). 
Other studies have demonstrated that the metabolites of green tea 
(for example the polyphenols catechins) are likely to be responsible for 
the beneficial health effects and may be biotransformed then metab-
olised further by the gut microbiota into phenolic acids (Higdon & Frei, 
2003; Ozdal et al., 2016). 
Research in dogs has demonstrated proportional changes within 
bacterial makeup of the gut microbiome, and this study similarly indi-
cated that medicinal effects of the introduction of green tea polyphenols 
can be directly correlated with microbiota induced changes, for example 
a decreased expression of inflammatory cytokines (Li et al., 2020). 
11.3. Cranberry 
Cranberry has been shown to be beneficial in gut-related inflam-
matory diseases like Inflammatory Bowel Disease (IBD), where gut 
dysbiosis occurs(Wang et al., 2018). A study has shown that, by 
increasing the intake of dietary cranberry or the fruits, the severity of 
IBD symptoms may be reduced. A significant decrease in severity of 
dextran sodium sulfate (DSS)-induced colitis was observed within a 
mouse model, decreasing disease activity and increasing colon length 
after dietary consumption of cranberry. This study also demonstrated 
reduced levels of pro-inflammatory cytokines and alterations in the 
faecal microbiota. Whilst there was a decrease of diversity with the 
diseased group compared to healthy control, cranberry treatment not 
only reduced this decline in diversity but also reversed the changes (Cai 
et al., 2017). This reversal of change is particularly interesting when 
considering soldiers as, not only is prevention or reduction of gut related 
diseases useful, but also the corrective reversal of changes in gut bacteria 
(increasing the abundance of beneficial bacteria such as Lactobacillus 
and Bifidobacterium whilst decreasing potentially harmful bacteria), is 
both useful and encouraging. What is interesting about this particular 
study is its use of dietary whole cranberry, which has large amounts of 
indigestible fibre and polyphenols, both of which can reach the colon. 
While it has not been confirmed that the improvements were due to the 
polyphenols, it is important to consider that the dietary polysaccharides 
found in the cranberry could increase SCFA production and alter bac-
terial composition in mice (Cai et al., 2017). 
Other research into the beneficial effects of cranberry includes a 
study using cranberry extract in diabetic mice to evaluate whether 
modulations of the gut microbiota play a role in reducing type 2 dia-
betes. Again, there was a potential metabolic impact of cranberry 
interacting with the gut microbiome, whether this be polyphenolic or 
because of a prebiotic effect. Whilst perhaps not at first glance directly 
relevant, this study did show that treatment with cranberry extract not 
only had an anti-diabetic effect but also alleviated intestinal inflam-
mation (Anhê et al., 2015). 
The primary ‘active’ polyphenols in cranberries are proanthocyani-
dins (Blumberg et al., 2013). In vitro studies have shown that these 
polyphenols have an antimicrobial effect, reducing E. coli levels in the 
gut (Harmidy et al., 2011; Roque, 2015) and, in vivo, they have been 
known to help reduce leaky gut, or dysfunction (Blumberg et al., 2013). 
This is where the use of cranberry extract could be particularly useful for 
the health and wellbeing of soldiers; not only is gut barrier dysfunction 
directly related to dysentery (König et al., 2016; Stewart et al., 2017), 
but it is also believed that stress exacerbates leaky gut (Vanuytsel et al., 
2014; Wallon et al., 2008) which can then lead to inflammation and 
mental health conditions such as depression and PTSD. (Leclercq et al., 
2016). 
11.4. Cocoa 
There has been a lot of research on the effects of cocoa polyphenols. 
Cocoa flavanols are able to cross the blood brain barrier and have been 
shown to improve cognition (Nehlig, 2013). Studies showed that cocoa 
flavonols were able to influence cognition in a number of ways although 
the exact mechanisms have not yet been fully understood. Research has 
shown that, through both direct and indirect actions, cognitive decline 
was reduced and general cognition, such as working memory, improved 
(Mastroiacovo et al., 2015; Socci et al., 2017). The flavonoids in cocoa, 
primarily epicatechin, have also been found to initiate neurogenesis 
(Valente et al., 2009). In common with other polyphenols, blood flow 
can be improved and, in the case of cocoa polyphenols, cerebral blood 
flow may be stimulated (Sorond et al., 2008), which may help reduce 
neuronal death. 
Neurodegenerative diseases are often related to neuroinflammation 
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(Chen et al., 2016). Many studies have shown that polyphenols have 
anti-inflammatory effects throughout the body, and the same is likely to 
be true in the brain (García-Lafuente et al., 2009). Low grade inflam-
mation associated with stroke (Zheng et al., 2003) and Alzheimer’s is 
thought to be caused by an inflammatory cascade (McGeer & McGeer, 
2003). Flavonols have been shown to reduce the effect of inflammation 
through cytokine release, amongst other processes (Leyva-López et al., 
2016). Modulation of signalling pathways, like the MAPK signalling 
cascade, can affect neuronal function via inhibitory or stimulatory ac-
tion that alters the target molecules, thereby altering gene expression 
(Spencer, 2007). One example of this comes from a study showing that 
oxidative damage could be prevented through anti-apoptotic action 
caused by direct action against the activation of caspase-3 (Schroeter 
et al., 2001). 
Research has also been able to identify specific gene expression 
related to polyphenol intake where (when combined with ERK1/2) the 
polyphenol epicatechin regulated gene expression through activation of 
CREB. This aids memory and neuroplasticity by promoting an expres-
sion of genes including those involved in angiogenesis (Schroeter et al., 
2006; van Praag et al., 2007). 
Although not directly related to polyphenol intake in military 
personnel under stress, studies have found that the intake of dark 
chocolate (i.e. cocoa) reduced urinary excretion of the stress hormone 
cortisol (Martin et al., 2009). However, research also concedes that 
chocolate feels comforting so some of the mood boosting effects may be 
psychosomatic (Parker et al., 2006). However, cocoa was seen to 
normalise the gut microbial activity seen in stressful situations, modi-
fying the gut microbiome within two weeks (Martin et al., 2009). 
Cocoa flavanols have also been seen to directly enhance pathways 
that increase brain-derived neurotrophic factor which, again, improves 
neuronal growth and health (Neshatdoust et al., 2016). Bacteria that 
have been identified as part of the gut microbial metabolism for cocoa 
polyphenols are E. coli, Bifidobacterium spp. (also found increased in 
faecal samples after the consumption of cocoa), Lactobacillus spp., Bac-
teroides spp., and Eubacterium spp (Cardona et al., 2013). Research has 
shown that beneficial bacteria are increased and pathogenic species like 
Clostridium are decreased after the intake of polyphenols (Duda-Chodak 
et al., 2015). 
It is, however, important to mention that cocoa is not the only food 
group that includes polyphenols that cross the blood brain barrier. In 
fact, in rats that had supplementation with blueberry polyphenols, 
specific polyphenols were subsequently found in the brain; anthocyanins 
were found in the cortex and hippocampus (Andres-Lacueva et al., 
2005). 
Whilst research has been carried out on individual polyphenols, most 
research focusses on the entire plant, that is a polyphenol mixture. There 
is likely much interaction, or crosstalk, between different compounds 
and phytochemicals within individual plants, and also within foods 
consumed alongside them. 
It may be less useful to discuss research that focusses on individual 
polyphenols than those studies considering the effects of whole plant 
foods. The interaction of different foods and the gut microbiota should 
be studied, but also more research is needed into whether or not other 
foods consumed with polyphenols affect bioavailability and activity of 
these chemicals. Furthermore, given that research suggests certain food 
types improve the health of the gut microbiota, it may be worth 
considering eliminating or reducing those foods that cause detriment to 
it, or rather cause dysbiosis (Brown et al., 2012). Otherwise, any benefits 
from introducing prebiotics and polyphenols to a diet could be negated. 
Controversially, a recent study found that a 15 day consumption of a 
blend of flavonoids from cocoa, blueberry and green tea exerted none of 
the expected effects on aspects of the gut microbiome normally associ-
ated with good health, such as SCFA concentrations, gut inflammation, 
or diversity of the gut microbiome (Kung et al., 2020). This is interesting 
as studies that have looked at separate contents of these flavonoids have 
found them to have a considerable impact. It may be that more dramatic 
effects are seen when these foods are combined with prebiotic in-
terventions. In this study, liquidised extracted samples were used in the 
intervention, so it may also be that whole food intake is more beneficial. 
Furthermore, in this study, only one faecal sample was taken between 
days 9–11 of the study, and a study in gnotobiotic mice showed that it 
might take 14 days to see differences in the gut microbiome after an 
increase of plants in the diet. Finally, it should also be taken into account 
that we may not see a massive change in the gut bacteria of people who 
already consume polyphenols, or rather those athletes who are likely to 
already have a good diet. These factors plus a fairly small sample size 
may be the reasons for this unexpected result. Notwithstanding, more 
research is needed to further investigate such findings. 
12. Pharmacomicrobiomics 
Not only is it important to explore nutrition as a treatment and 
preventative measure for PTSD, but understanding the impact of the gut 
microbiota on metabolism is also crucial given the potential differences 
in metabolism of pharmacological treatments in individuals. Currently 
available medications, such as Selective Serotonin Reuptake Inhibitors 
(SSRIs), are limited in their benefit; they are not specifically designed for 
PTSD, and will often have less than a 30% patient full remit (Berger 
et al., 2009). Exploring the optimisation of drugs through pharmaco-
microbiomics could be a way to improve patient remit and drug efficacy. 
It is also important to consider that drugs for PTSD have been shown to 
be effective prophylactically (Litz, 2008; Roque, 2015). Given that 
nutritional interventions have had the same effect in disorders such as 
depression, it is reasonable to posit that a nutritional intervention could 
also be successful prophylactically in PTSD (Rechenberg & Humphries, 
2013). Research has suggested that treating PTSD earlier or at the sub-
clinical level is beneficial in terms of the reduction of symptoms and 
developmental trajectory of the disorder (Korte et al., 2016). 
Pharmacomicrobiomics considers the interplay of inter-individual 
microbiome variation and the response to drugs (Doestzada et al., 
2018). Long term perturbations such as stress can disrupt the gut 
microbiome environment, causing detriment to the homeostatic envi-
ronment surrounding the gut-brain axis (Carabotti et al., 2015). This 
disturbance is likely to worsen hypothalamic–pituitary–adrenal (HPA) 
axis function and immune function, given the ways in which the gut 
ecosystem interacts and triggers physiological changes in the brain. 
Differences in an individual’s drug response can not only cause 
detriment economically to society if it causes the treatment to fail, but 
can also seriously affect a patients wellbeing (Sultana et al., 2013). 
Improving the efficacy in the kinetics of drugs is always desirable 
(Sharma et al., 2019). However, given that personalised medicine is 
expensive and time consuming, (Vogenberg et al., 2010) finding a 
nutritional intervention that could increase beneficial bacteria in the 
gut, reduce the detrimental effects of certain disorders and potentially 
increase the efficacy of certain drugs could be of huge benefit. 
13. Conclusion 
By using the gut microbiota as a therapeutic target to exploit the 
bidirectional gut-brain axis, it may be possible to address neuropsychi-
atric conditions, such as PTSD. This is very exciting, as diet is one of the 
most modifiable factors of the gut microbiota, at all points in life, 
regardless of health status (Leeming et al., 2019). Effective remedies are 
urgently needed for the negative consequences of stress, dysentery and 
PTSD seen within military personnel. There appears to be no detriment 
to health from increasing authentic prebiotic and polyphenol intake in 
the diet, especially if it is through consumption of whole foods rather 
than supplementation of individual polyphenol extracts. The use of 
prebiotics and polyphenols to treat neuropsychiatric and physical con-
ditions in military personnel looks very promising. That said, more 
research is needed to identify specific bacterial metabolites and specific 
bacterial gene expression for combinatorial polyphenol food groups 
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before safety and efficacy can be confirmed. 
14. Ethics statement 
No animal or human experimentation was conducted in this review 
manuscript. 
Declaration of Competing Interest 
The authors declare that they have no known competing financial 
interests or personal relationships that could have appeared to influence 
the work reported in this paper. 
References 
Abbas, M., Saeed, F., Anjum, F. M., Afzaal, M., Tufail, T., Bashir, M. S., Ishtiaq, A., 
Hussain, S., & Suleria, H. A. R. (2017). Natural polyphenols: An overview. 
International Journal of Food Properties, 20(8), 1689–1699. https://doi.org/10.1080/ 
10942912.2016.1220393. 
Agans, R. T., Giles, G. E., Goodson, M. S., Karl, J. P., Leyh, S., Mumy, K. L., Racicot, K., & 
Soares, J. W. (2020). Evaluation of probiotics for warfighter health and performance. 
Frontiers in Nutrition, 7, 70. https://doi.org/10.3389/fnut.2020.00070. 
Allen, S. J., Okoko, B., Martinez, E., Gregorio, G., & Dans, L. F. (2004). Probiotics for 
treating infectious diarrhoea. Cd003048 Cochrane Database of Systematic Reviews, 2. 
https://doi.org/10.1002/14651858.CD003048.pub2. 
Alves-Santos, A. M., Sugizaki, C. S. A., Lima, G. C., & Naves, M. M. V. (2020). Prebiotic 
effect of dietary polyphenols: A systematic review. Journal of Functional Foods, 74, 
104169. https://doi.org/10.1016/j.jff.2020.104169. 
Andres-Lacueva, C., Shukitt-Hale, B., Galli, R. L., Jauregui, O., Lamuela-Raventos, R. M., 
& Joseph, J. A. (2005). Anthocyanins in aged blueberry-fed rats are found centrally 
and may enhance memory. Nutritional Neuroscience, 8(2), 111–120. https://doi.org/ 
10.1080/10284150500078117. 
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Gómez-Pinilla, F. (2008). Brain foods: The effects of nutrients on brain function. Nature 
reviews. Neuroscience, 9(7), 568–578. https://doi.org/10.1038/nrn2421. 
Guinane, C. M., & Cotter, P. D. (2013). Role of the gut microbiota in health and chronic 
gastrointestinal disease: Understanding a hidden metabolic organ. Therapeutic 
Advances in Gastroenterology, 6(4), 295–308. https://doi.org/10.1177/ 
1756283X13482996. 
Hadrich, D. (2018). Microbiome research is becoming the key to better understanding 
health and nutrition. Frontiers in Genetics, 9, 212. https://doi.org/10.3389/ 
fgene.2018.00212. 
Han, H., Liu, C., Gao, W., Li, Z., Qin, G., Qi, S., … Hu, C. Y. (2021). Anthocyanins Are 
Converted into Anthocyanidins and Phenolic Acids and Effectively Absorbed in the 
Jejunum and Ileum. Journal of Agricultural and Food Chemistry, 69(3), 992–1002. 
Harmidy, K., Tufenkji, N., Gruenheid, S., & Bereswill, S. (2011). Perturbation of host cell 
cytoskeleton by cranberry proanthocyanidins and their effect on enteric infections. 
PLOS ONE, 6(11), e27267. https://doi.org/10.1371/journal.pone.002726710.1371/ 
journal.pone.0027267.s00110.1371/journal.pone.0027267.s002. 
He, F., Li, J., Liu, Z., Chuang, C.-C., Yang, W., & Zuo, L. (2016). Redox mechanism of 
reactive oxygen species in exercise. Frontiers in Physiology, 7, 486. https://doi.org/ 
10.3389/fphys.2016.00486. 
Hegde, M., Wood, T. K., & Jayaraman, A. (2009). The neuroendocrine hormone 
norepinephrine increases Pseudomonas aeruginosa PA14 virulence through the las 
quorum-sensing pathway. Applied Microbiology and Biotechnology, 84, 763–776. 
https://doi.org/10.1007/s00253-009-2045-1. 
Heiman, M. L., & Greenway, F. L. (2016). A healthy gastrointestinal microbiome is 
dependent on dietary diversity. Molecular Metabolism, 5(5), 317–320. https://doi. 
org/10.1016/j.molmet.2016.02.005. 
Hernández, M., Canfora, E. E., Jocken, J., & Blaak, E. E. (2019). The Short-Chain Fatty 
Acid Acetate in Body Weight Control and Insulin Sensitivity. Nutrients, 11(8), 1943. 
https://doi.org/10.3390/nu11081943. 
Hidalgo, M., Oruna-Concha, M. J., Kolida, S., Walton, G. E., Kallithraka, S., Spencer, J. P., 
& de Pascual-Teresa, S. (2012). Metabolism of anthocyanins by human gut 
microflora and their influence on gut bacterial growth. Journal of agricultural and 
food chemistry, 60(15), 3882–3890. 
Higdon, J. V., & Frei, B. (2003). Tea catechins and polyphenols: Health effects, 
metabolism, and antioxidant functions. Critical Reviews in Food Science and Nutrition, 
43(1), 89–143. https://doi.org/10.1080/10408690390826464. 
Hill, C., Guarner, F., Reid, G., Gibson, G. R., Merenstein, D. J., Pot, B., Morelli, L., 
Canani, R. B., Flint, H. J., Salminen, S., Calder, P. C., & Sanders, M. E. (2014). Expert 
consensus document. The International Scientific Association for Probiotics and 
Prebiotics consensus statement on the scope and appropriate use of the term 
probiotic. Nature Reviews Gastroenterology and Hepatololgy, 11(8), 506–514. https:// 
doi.org/10.1038/nrgastro.2014.66. 
Hill, N., Fallowfield, J., Price, S., & Wilson, D. (2011). Military nutrition: Maintaining 
health and rebuilding injured tissue. Philosophical Transactions of the Royal Society of 
London Series B, Biological Sciences, 366(1562), 231–240. https://doi.org/10.1098/ 
rstb.2010.0213. 
Holscher, H. D. (2017). Dietary fiber and prebiotics and the gastrointestinal microbiota. 
Gut microbes, 8(2), 172–184. https://doi.org/10.1080/19490976.2017.1290756. 
Human Microbiome Project C. (2012). Structure, function and diversity of the healthy 
human microbiome. Nature, 486(7402), 207–214. https://doi.org/10.1038/ 
nature11234. 
Hussain, T., Tan, B., Yin, Y., Blachier, F., Tossou, M. C. B., & Rahu, N. (2016). Oxidative 
stress and inflammation: what polyphenols can do for us? Oxidative Medicine and 
Cellular Longevity, 2016, Article 7432797. https://doi.org/10.1155/2016/7432797. 
Iorio, N., Makipour, K., Palit, A., & Friedenberg, F. K. (2014). Post-traumatic stress 
disorder is associated with irritable bowel syndrome in African Americans. Journal of 
neurogastroenterology and motility, 20(4), 523–530. https://doi.org/10.5056/ 
jnm14040. 
Iribarren, J., Prolo, P., Neagos, N., & Chiappelli, F. (2005). Post-traumatic stress disorder: 
Evidence-based research for the third millennium. Evidence-Based Complementary and 
Alternative Medicine: ECAM, 2(4), 503–512. https://doi.org/10.1093/ecam/neh127. 
Irwin, C., Falsetti, S. A., Lydiard, R. B., Ballenger, J. C., Brock, C. D., & Brener, W. (1996). 
Comorbidity of posttraumatic stress disorder and irritable bowel syndrome. Journal 
of Clinical Psychiatry, 57(12), 576–578. https://doi.org/10.4088/jcp.v57n1204. 
Jackson, M. I., & Jewell, D. E. (2017). Impact of fiber-bound polyphenols on gut 
microbiome metabolism is influenced by background diet. The FASEB Journal, 31. 
https://doi.org/10.1096/fasebj.31.1_supplement.792.23, 792.23-792.23. 
Jelena, C. H., Giorgio, R., Justyna, G., Neda, M.-D., Natasa, S., Artur, B., & Giuseppe, G. 
(2018). 3 - Beneficial effects of polyphenols on chronic diseases and ageing. In C. M. 
Galanakis (Ed.), Polyphenols: Properties, recovery, and applications (pp. 69–102). 
https://doi.org/https://doi.org/10.1016/B978-0-12-813572-3.00003-8. 
Jung, E. S., Park, J. I., Holzapfel, W., Hwang, J. S., & Lee, C. H. (2019). Seven-day green 
tea supplementation revamps gut microbiome and caecum/skin metabolome in mice 
from stress. Scientific Reports, 9(1), 18418. https://doi.org/10.1038/s41598-019- 
54808-5. 
Kardum, N., & Glibetic, M. (2018). Polyphenols and their interactions with other dietary 
compounds: Implications for human health (Vol. 84,, 103–144. 
B. Sayers et al.                                                                                                                                                                                                                                  
Journal of Functional Foods 87 (2021) 104753
13
Karl, J. P., Margolis, L. M., Madslien, E. H., Murphy, N. E., Castellani, J. W., 
Gundersen, Y., Hoke, A. V., Levangie, M. W., Kumar, R., Chakraborty, N., 
Gautam, A., Hammamieh, R., Martini, S., Montain, S. J., & Pasiakos, S. M. (2017). 
Changes in intestinal microbiota composition and metabolism coincide with 
increased intestinal permeability in young adults under prolonged physiological 
stress. American Journal of Physiology-Gastrointestinal and Liver Physiology, 312(6), 
G559–G571. https://doi.org/10.1152/ajpgi.00066.2017. 
Karl, J. P., Armstrong, N. J., McClung, H. L., Player, R. A., Rood, J. C., Racicot, K., 
Soares, J. W., & Montain, S. J. (2019). A diet of U.S. military food rations alters gut 
microbiota composition and does not increase intestinal permeability. The Journal of 
Nutritional Biochemistry, 72, Article 108217. https://doi.org/10.1016/j. 
jnutbio.2019.108217. 
Karl, J. P., Hatch, A. M., Arcidiacono, S. M., Pearce, S. C., Pantoja-Feliciano, I. G., 
Doherty, L. A., & Soares, J. W. (2018). Effects of psychological, environmental and 
physical stressors on the gut microbiota. Frontiers in Microbiology, 9, 2013. https:// 
doi.org/10.3389/fmicb.2018.02013. 
Kellow, N. J., Coughlan, M. T., & Reid, C. M. (2014). Metabolic benefits of dietary 
prebiotics in human subjects: A systematic review of randomised controlled trials. 
British Journal of Nutrition, 111(7), 1147–1161. https://doi.org/10.1017/ 
S0007114513003607. 
Kelly, J. R., Kennedy, P. J., Cryan, J. F., Dinan, T. G., Clarke, G., & Hyland, N. P. (2015). 
Breaking down the barriers: The gut microbiome, intestinal permeability and stress- 
related psychiatric disorders. Frontiers in Cellular Neuroscience, 9, 392. https://doi. 
org/10.3389/fncel.2015.00392. 
Kennedy, D. O. (2014). Polyphenols and the human brain: Plant “secondary metabolite” 
ecologic roles and endogenous signaling functions drive benefits. Advances in 
Nutrition, 5(5), 515–533. 
Keppler, K., & Humpf, H.-U. (2005). Metabolism of anthocyanins and their phenolic 
degradation products by the intestinal microflora. Bioorganic & Medicinal Chemistry, 
13(17), 5195–5205. 
Kho, Z. Y., & Lal, S. K. (2018). The human gut microbiome – a potential controller of 
wellness and disease. Frontiers in Microbiology, 9(1835). https://doi.org/10.3389/ 
fmicb.2018.01835. 
Khurana, S., Venkataraman, K., Hollingsworth, A., Piche, M., & Tai, T. C. (2013). 
Polyphenols: Benefits to the cardiovascular system in health and in aging. Nutrients, 
5(10), 3779–3827. https://doi.org/10.3390/nu5103779. 
Kim, D. H., & Jin, Y. H. (2001). Intestinal bacterial beta-glucuronidase activity of patients 
with colon cancer. Archives of Pharmacal Research, 24(6), 564–567. https://doi.org/ 
10.1007/bf02975166. 
Kim, J., Yoon, S., Lee, S., Hong, H., Ha, E., Joo, Y., Lee, E. H., & Lyoo, I. K. (2020). 
A double-hit of stress and low-grade inflammation on functional brain network 
mediates posttraumatic stress symptoms. Nature Communications, 11(1), 1898. 
https://doi.org/10.1038/s41467-020-15655-5. 
Kim, T. D., Lee, S., & Yoon, S. (2020). Inflammation in post-traumatic stress disorder 
(ptsd): A review of potential correlates of ptsd with a neurological perspective. 
Antioxidants (Basel, Switzerland), 9(2), 107. https://doi.org/10.3390/ 
antiox9020107. 
Knekt, P., Kumpulainen, J., Järvinen, R., Rissanen, H., Heliövaara, M., Reunanen, A., 
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Food sources and bioavailability. The American Journal of Clinical Nutrition, 79(5), 
727–747. https://doi.org/10.1093/ajcn/79.5.727. 
Mandel, S., & Youdim, M. B. H. (2004). Catechin polyphenols: Neurodegeneration and 
neuroprotection in neurodegenerative diseases. Free Radical Biology and Medicine, 37 
(3), 304–317. https://doi.org/10.1016/j.radbiomed.2004.04.012. 
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